| Date Filed | Type | Description |
| 07/18/2023 |
4
| Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,075 shares
@ $2.56, valued at
$25.8k
|
|
| 07/05/2023 |
4
| Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 682 shares
@ $2.46, valued at
$1.7k
|
|
| 06/08/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| Levy Richard S (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| Solomon Michael Edward (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| Flannelly Barry P (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 01/30/2023 |
4
| Fabbio Patrick (CFO) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.14, valued at
$942k
|
|
| 01/30/2023 |
3
| Fabbio Patrick (CFO) has filed a Form 3 on Protara Therapeutics, Inc. |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 35,400 options to buy
@ $3.02, valued at
$106.9k
|
|
| 01/20/2023 |
4
| Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 19,900 shares
@ $0
Granted 119,300 options to buy
@ $3.02, valued at
$360.3k
|
|
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,225 shares
@ $3, valued at
$15.7k
|
|
| 01/11/2023 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,855 shares
@ $3, valued at
$17.6k
|
|
| 01/11/2023 |
4
| Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,876 shares
@ $3, valued at
$5.6k
|
|
| 01/04/2023 |
4
| Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,159 shares
@ $2.8, valued at
$6k
|
|
| 01/04/2023 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,604 shares
@ $2.8, valued at
$18.5k
|
|
| 01/04/2023 |
4
| Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 361 shares
@ $2.8, valued at
$1k
|
|
| 12/30/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Sold 13,173 shares
@ $2.7111, valued at
$35.7k
Sold 2,300 shares
@ $2.7111, valued at
$6.2k
|
|
| 09/15/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 14,100 shares
@ $3.98, valued at
$56.1k
Bought 2,500 shares
@ $3.98, valued at
$10k
Bought 5,000 shares
@ $3.8, valued at
$19k
Bought 2,300 shares
@ $3.8, valued at
$8.7k
|
|
| 08/15/2022 |
4
| Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 9,065 shares
@ $3.84, valued at
$34.8k
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2022 |
4
| Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 682 shares
@ $3.22, valued at
$2.2k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.5, valued at
$35k
|
|
| 06/09/2022 |
4
| SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.5, valued at
$35k
|
|
| 06/09/2022 |
4
| Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.5, valued at
$35k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|